The blood sugar of the diabetic mice were made normal by the gene - therapy -
treated human islets on the right.
Not exact matches
In these two microscopy images,
human islets (the source of insulin cells) were poisoned with a drug to remove the insulin cells, and then
treated with either an empty virus (left panel) or the therapeutic virus (right panel), and then grown in a diabetic mouse.
The load of IAPP aggregates in
islets treated with old Tg - hIAPP
islet homogenate was significantly greater than that of the control groups, including untreated
human islets and those exposed to the same concentration of WT
islet extracts lacking IAPP aggregates (Fig. 2 D).
(C)
Human islets, isolated postmortem from nondiabetic individuals, were
treated with 1 %
islet homogenate from old Tg - hIAPP mice, WT control
islet homogenates, or old Tg - hIAPP immunodepleted using a cocktail of sequence and conformational antibodies.
Similar results were obtained when
human islets were
treated with synthetic IAPP aggregates (Fig. 2, C and D).
Maturation of
human embryonic stem cell - derived pancreatic progenitors into functional
islets capable of
treating pre-existing diabetes in mice.